| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T50 |
0-8 |
Sentence |
denotes |
Table 1. |
| T51 |
9-88 |
Sentence |
denotes |
Classification of viruses and the kinase inhibitors showing antiviral activity. |
| T52 |
89-190 |
Sentence |
denotes |
Virus Baltimore classification Kinase inhibitors showing antiviral activity(potential kinase targets) |
| T53 |
191-261 |
Sentence |
denotes |
SARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib |
| T54 |
262-351 |
Sentence |
denotes |
(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full) |
| T55 |
352-390 |
Sentence |
denotes |
abemaciclib, gilteritinib, osimertinib |
| T56 |
391-414 |
Sentence |
denotes |
(unpublished; preprint: |
| T57 |
415-484 |
Sentence |
denotes |
https://www.biorxiv.org/content/10.1101/2020.03.20.999730v3.full.pdf) |
| T58 |
485-582 |
Sentence |
denotes |
SARS-CoV Group IV, positive sense single-stranded RNA virus imatinib, dasatinib, nilotinib (ABL2) |
| T59 |
583-592 |
Sentence |
denotes |
(27) (29) |
| T60 |
593-684 |
Sentence |
denotes |
MERS-CoV Group IV, positive sense single-stranded RNA virus imatinib, dasatinib (ABL2) (27) |
| T61 |
685-712 |
Sentence |
denotes |
saracatinib (LYN, FYN) (33) |
| T62 |
713-733 |
Sentence |
denotes |
sorafenib (RAF) (68) |
| T63 |
734-840 |
Sentence |
denotes |
Dengue Group IV, positive sense single-stranded RNA virus dasatinib, saracatinib (SRC, FYN) (34) (35) (36) |
| T64 |
841-893 |
Sentence |
denotes |
sunitinib, erlotinib (AAK1, GAK, AXL, KIT, RET) (46) |
| T65 |
894-999 |
Sentence |
denotes |
Hepatitis C Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (AAK1, GAK) (41) (42) |
| T66 |
1000-1043 |
Sentence |
denotes |
gefitinib, erlotinib (EGFR) (59) ((56) (57) |
| T67 |
1044-1130 |
Sentence |
denotes |
West Nile Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (46) |
| T68 |
1131-1212 |
Sentence |
denotes |
Zika Group IV, positive sense single-stranded RNA virus sunitinib, erlotinib (46) |
| T69 |
1213-1290 |
Sentence |
denotes |
Ebola Group V, negative sense single-stranded RNA virus nilotinib (ABL1) (24) |
| T70 |
1291-1369 |
Sentence |
denotes |
Influenza A Group V, negative sense single-stranded RNA virus alvocidib (CDK9) |
| T71 |
1370-1469 |
Sentence |
denotes |
Human cytomegalovirus Group 1, double-stranded DNA virus gefitinib, erlotinib (EGFR) (59) (57) (56) |
| T72 |
1470-1533 |
Sentence |
denotes |
Vaccinia Group 1, double-stranded DNA virus imatinib (ABL) (25) |
| T73 |
1534-1614 |
Sentence |
denotes |
Herpes simplex type 1 Group 1, double-stranded DNA virus palbociclib (CDK6) (62) |
